BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22321962)

  • 1. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.
    López M; San Román J; Estrada V; Vispo E; Blanco F; Soriano V
    AIDS Rev; 2012; 14(4):223-30. PubMed ID: 23258297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial progenitor cells, microparticles and vascular disease.
    Mehta JL; Szwedo J
    J Hypertens; 2010 Aug; 28(8):1611-3. PubMed ID: 20647855
    [No Abstract]   [Full Text] [Related]  

  • 4. Microparticles: biomarkers and beyond.
    Burger D; Schock S; Thompson CS; Montezano AC; Hakim AM; Touyz RM
    Clin Sci (Lond); 2013 Apr; 124(7):423-41. PubMed ID: 23249271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial microparticles: missing link in endothelial dysfunction?
    Yong PJ; Koh CH; Shim WS
    Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
    Pericleous C; Giles I; Rahman A
    Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial injury and repair in systemic vasculitis of the young.
    Clarke LA; Hong Y; Eleftheriou D; Shah V; Arrigoni F; Klein NJ; Brogan PA
    Arthritis Rheum; 2010 Jun; 62(6):1770-80. PubMed ID: 20178138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
    Amabile N; Guérin AP; Leroyer A; Mallat Z; Nguyen C; Boddaert J; London GM; Tedgui A; Boulanger CM
    J Am Soc Nephrol; 2005 Nov; 16(11):3381-8. PubMed ID: 16192427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, cell differentiation, angiogenesis--microparticles and their roles in angiogenesis.
    Shai E; Varon D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):10-4. PubMed ID: 21160063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles.
    Stiefel P; Sánchez-Armengol MA; Villar J; Vallejo-Vaz A; Moreno-Luna R; Capote F
    Arch Med Res; 2013 Aug; 44(6):409-14. PubMed ID: 24051041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of left ventricle assist device on circulating endothelial microparticles - pilot study.
    Pitha J; Dorazilova Z; Melenovsky V; Kralova Lesna I; Stavek P; Stepankova J; Urban M; Maly J; Netuka I
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():68-72. PubMed ID: 23183513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transplanted circulating endothelial progenitor cells and platelet microparticles in atherosclerosis development.
    Georgescu A; Alexandru N; Andrei E; Dragan E; Cochior D; Dias S
    Biol Cell; 2016 Aug; 108(8):219-43. PubMed ID: 26968123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome.
    La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero AE
    J Androl; 2012; 33(2):202-9. PubMed ID: 21474787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia-associated endothelial progenitor cell dysfunction.
    Pirro M; Bagaglia F; Paoletti L; Razzi R; Mannarino MR
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):329-39. PubMed ID: 19124431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients.
    Wang JM; Su C; Wang Y; Huang YJ; Yang Z; Chen L; Wu F; Xu SY; Tao J
    J Hum Hypertens; 2009 May; 23(5):307-15. PubMed ID: 19037229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.